ARCC Q1 2026 Earnings Net Investment Income Misses Estimates Amid Stable Portfolio Performance UPXI Q1 2026 Earnings Significant EPS Miss Drives Stock Decline TATT Q1 2026 Earnings Strong EPS Beat Drives Stock Rally KMPR Q1 2026 Earnings EPS Falls Short of Estimates as Underwriting Challenges Persist NovaBridge Biosciences NBP Q4 2025 Earnings Staggering EPS Miss as PreRevenue Biotech Faces Development Headwinds ADT Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Decline